Long-term survival and development of secondary malignancies in patients with acute myeloid leukemia treated with aclarubicin or daunorubicin plus cytosine arabinoside followed by intensive consolidation chemotherapy in a Danish national phase III t (Q50560177)
Jump to navigation
Jump to search
scientific article published in January 1997
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Long-term survival and development of secondary malignancies in patients with acute myeloid leukemia treated with aclarubicin or daunorubicin plus cytosine arabinoside followed by intensive consolidation chemotherapy in a Danish national phase III t |
scientific article published in January 1997 |
Statements
Long-term survival and development of secondary malignancies in patients with acute myeloid leukemia treated with aclarubicin or daunorubicin plus cytosine arabinoside followed by intensive consolidation chemotherapy in a Danish national phase III t (English)
1 reference
de Nully Brown P
1 reference
Hoffmann T
1 reference
Hansen OP
1 reference
Boesen AM
1 reference
Grønbaek K
1 reference
Hippe E
1 reference
Jensen MK
1 reference
Thorling K
1 reference
Pedersen-Bjergaard J
1 reference
1 January 1997
1 reference
1 reference
11
1 reference
1
1 reference
37-41
1 reference
Identifiers
1 reference